Achieve Life Sciences Inc (ACHV)
4.68
-0.07
(-1.47%)
USD |
NASDAQ |
May 08, 09:55
Achieve Life Sciences Enterprise Value: 163.86M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 163.86M |
| May 06, 2024 | 157.70M |
| May 03, 2024 | 163.35M |
| May 02, 2024 | 161.81M |
| May 01, 2024 | 155.98M |
| April 30, 2024 | 151.53M |
| April 29, 2024 | 157.70M |
| April 26, 2024 | 159.07M |
| April 25, 2024 | 157.87M |
| April 24, 2024 | 156.67M |
| April 23, 2024 | 155.30M |
| April 22, 2024 | 152.22M |
| April 19, 2024 | 155.64M |
| April 18, 2024 | 157.70M |
| April 17, 2024 | 157.70M |
| April 16, 2024 | 151.19M |
| April 15, 2024 | 153.59M |
| April 12, 2024 | 149.99M |
| April 11, 2024 | 151.53M |
| April 10, 2024 | 151.19M |
| April 09, 2024 | 150.50M |
| April 08, 2024 | 150.50M |
| April 05, 2024 | 153.93M |
| April 04, 2024 | 154.61M |
| April 03, 2024 | 158.38M |
| Date | Value |
|---|---|
| April 02, 2024 | 154.61M |
| April 01, 2024 | 158.04M |
| March 28, 2024 | 156.84M |
| March 27, 2024 | 155.98M |
| March 26, 2024 | 160.78M |
| March 25, 2024 | 161.12M |
| March 22, 2024 | 158.72M |
| March 21, 2024 | 158.72M |
| March 20, 2024 | 160.78M |
| March 19, 2024 | 157.35M |
| March 18, 2024 | 158.72M |
| March 15, 2024 | 158.38M |
| March 14, 2024 | 153.93M |
| March 13, 2024 | 152.56M |
| March 12, 2024 | 150.16M |
| March 11, 2024 | 150.16M |
| March 08, 2024 | 151.53M |
| March 07, 2024 | 151.19M |
| March 06, 2024 | 152.90M |
| March 05, 2024 | 151.53M |
| March 04, 2024 | 152.56M |
| March 01, 2024 | 94.72M |
| February 29, 2024 | 86.89M |
| February 28, 2024 | 95.57M |
| February 27, 2024 | 96.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.453M
Minimum
Mar 16 2020
179.00M
Maximum
May 10 2023
45.78M
Average
35.89M
Median
Nov 26 2021
Enterprise Value Benchmarks
| Accelerate Diagnostics Inc | 43.11M |
| Atossa Therapeutics Inc | 125.81M |
| ENDRA Life Sciences Inc | 0.6344M |
| Perspective Therapeutics Inc | 1.072B |
| Electromed Inc | 140.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.476M |
| Total Expenses (Quarterly) | 4.386M |
| EPS Diluted (Quarterly) | -0.24 |
| Earnings Yield | -32.26% |
| Normalized Earnings Yield | -31169.06 |